Predicting the Progression of Mild Cognitive Impairment to Alzheimer’s Dementia Using Recurrent Neural Networks With a Series of Neuropsychological Tests
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose The prevalence of Alzheimer’s dementia (AD) is increasing as populations age, causing immense suffering for patients, families, and communities. Unfortunately, no treatments for this neurodegenerative disease have been established. Predicting AD is therefore becoming more important, because early diagnosis is the best way to prevent its onset and delay its progression. Methods Mild cognitive impairment (MCI) is the stage between normal cognition and AD, with large variations in its progression. The disease can be effectively managed by accurately predicting the probability of MCI progressing to AD over several years. In this study we used the Alzheimer’s Disease Neuroimaging Initiative dataset to predict the progression of MCI to AD over a 3-year period from baseline. We developed and compared various recurrent neural network (RNN) models to determine the predictive effectiveness of four neuropsychological (NP) tests and magnetic resonance imaging (MRI) data at baseline. Results The experimental results confirmed that the Preclinical Alzheimer’s Cognitive Composite score was the most effective of the four NP tests, and that the prediction performance of the NP tests improved over time. Moreover, the gated recurrent unit model exhibited the best performance among the prediction models, with an average area under the receiver operating characteristic curve of 0.916 Conclusions Timely prediction of progression from MCI to AD can be achieved using a series of NP test results and an RNN, both with and without using the baseline MRI data.
Abstract
Background and Purpose The prevalence of Alzheimer’s dementia (AD) is increasing as populations age, causing immense suffering for patients, families, and communities. Unfortunately, no treatments for this neurodegenerative disease have been established. Predicting AD is therefore becoming more important, because early diagnosis is the best way to prevent its onset and delay its progression. Methods Mild cognitive impairment (MCI) is the stage between normal cognition and AD, with large variations in its progression. The disease can be effectively managed by accurately predicting the probability of MCI progressing to AD over several years. In this study we used the Alzheimer’s Disease Neuroimaging Initiative dataset to predict the progression of MCI to AD over a 3-year period from baseline. We developed and compared various recurrent neural network (RNN) models to determine the predictive effectiveness of four neuropsychological (NP) tests and magnetic resonance imaging (MRI) data at baseline. Results The experimental results confirmed that the Preclinical Alzheimer’s Cognitive Composite score was the most effective of the four NP tests, and that the prediction performance of the NP tests improved over time. Moreover, the gated recurrent unit model exhibited the best performance among the prediction models, with an average area under the receiver operating characteristic curve of 0.916 Conclusions Timely prediction of progression from MCI to AD can be achieved using a series of NP test results and an RNN, both with and without using the baseline MRI data.
참고문헌 (33)
- Therriault J, "Staging of Alzheimer’s disease : past, present, and future perspectives", Trends Mol Med, 28, pp.726~741 (2022)
- Morris JC, "Early-stage and preclinical Alzheimer disease", Alzheimer Dis Assoc Disord, 19, pp.163~165 (2005)
- Isik AT, "Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer’s disease : a narrative review", Int J Geriatr Psychiatry, 34, pp.1326~1334 (2019)
- Vaz M, "Alzheimer’s disease : recent treatment strategies", Eur J Pharmacol, 887, pp.173554~ (2020)
- Yiannopoulou KG, "Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research", Biomedicines, 7, pp.97~ (2019)
- World Alzheimer report 2022. Life after diagnosis: navigating treatment, care and support, "Gauthier S", Alzheimer’s Disease International, ~ (2022)
- Bari Antor M, "A comparative analysis of machine learning algorithms to predict Alzheimer’s disease", J Healthc Eng, 2021, pp.9917919~ (2021)
- Basaia S, "Automated classification of Alzheimer’s disease and mild cognitive impairment using a single MRI and deep neural networks", Neuroimage Clin, 21, pp.101645~ (2019)
- Ge XY, "Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease", Sci Rep, 11, pp.17558~ (2021)
- Jack CR Jr, "The Alzheimer’s Disease Neuroimaging Initiative(ADNI) : MRI methods", J Magn Reson Imaging, 27, pp.685~691 (2008)
- Hamza EA, "Effect of APOE4 allele and gender on the rate of atrophy in the hippocampus, entorhinal cortex, and fusiform gyrus in Alzheimer’s disease", Curr Alzheimer Res, 19, pp.943~953 (2022)
- "Main page"[URL]
- Fischl B, "Measuring the thickness of the human cerebral cortex from magnetic resonance images", Proc Natl Acad Sci U S A, 97, pp.11050~11055 (2000)
- Insel PS, "Determining clinically meaningful decline in preclinical Alzheimer disease", Neurology, 93, pp.e322~e333 (2019)
- Chandra A, "Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment", J Neurol, 266, pp.1293~1302 (2019)
- Bayram E, "Current understanding of magnetic resonance imaging biomarkers and memory in Alzheimer’s disease", Alzheimers Dement(N Y), 4, pp.395~413 (2018)
- Arevalo-Rodriguez I, "Mini-mental state examination(MMSE)for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment(MCI)", Cochrane Database Syst Rev, 2015, pp.CD010783~ (2015)
- Rosen WG, "A new rating scale for Alzheimer’s disease", Am J Psychiatry, 141, pp.1356~1364 (1984)
- Cano SJ, "The ADAS-cog in Alzheimer’s disease clinical trials : psychometric evaluation of the sum and its parts", J Neurol Neurosurg Psychiatry, 81, pp.1363~1368 (2010)
- Seghezzo G, "Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite(PACC)score via videoconferencing", J Neurol, 268, pp.2228~2237 (2021)
- Arbuthnott K, "Trail making test, part B as a measure of executive control : validation using a set-switching paradigm", J Clin Exp Neuropsychol, 22, pp.518~528 (2000)
- Ashendorf L, "Trail making test errors in normal aging, mild cognitive impairment, and dementia", Arch Clin Neuropsychol, 23, pp.129~137 (2008)
- Stone M, "Cross-validatory choice and assessment of statistical predictions", J R Stat Soc Series B Stat Methodol, 36, pp.111~133 (1974)
- "Study the influence of normalization/transformation process on the accuracy of supervised classification"[URL]
- Rumelhart DE, "Learning internal representations by error propagation" (2023), MIT Press
- Hochreiter S, "Long short-term memory", Neural Comput, 9, pp.1735~1780 (1997)
- Song J, "An effective multimodal image fusion method using MRI and PET for Alzheimer’s disease diagnosis", Front Digit Health, 3, pp.637386~ (2021)
- Venugopalan J, "Multimodal deep learning models for early detection of Alzheimer’s disease stage", Sci Rep, 11, pp.3254~ (2021)
- Ding Y, "Quantitative radiomic features as new biomarkers for Alzheimer’s disease : an amyloid PET study", Cereb Cortex, 31, pp.3950~3961 (2021)
- Varatharajah Y, "Predicting short-term MCI-to-AD progression using imaging, CSF, genetic factors, cognitive resilience, and demographics", Sci Rep, 9, pp.2235~ (2019)
- Platero C, "Predicting Alzheimer’s conversion in mild cognitive impairment patients using longitudinal neuroimaging and clinical markers", Brain Imaging Behav, 15, pp.1728~1738 (2021)